Rosuvastatin Market Poised for Steady Growth Driven by Rising Cardiovascular Concerns: A Detailed Analysis

The global rosuvastatin market is expected to witness continued growth in the coming years, driven by the increasing prevalence of cardiovascular diseases (CVDs) and the growing geriatric population. Rosuvastatin, a statin drug used to lower cholesterol levels and reduce the risk of heart attacks and strokes, is a vital component in managing CVDs, a leading cause of death globally.

To avail Sample Copy of the report @ https://www.reportsanddata.com/download-free-sample/1650

Market Overview and Trends

Rising CVD Burden: According to the World Health Organization (WHO), CVDs are responsible for an estimated 18.6 million deaths globally each year. This growing burden fuels the demand for effective cholesterol-lowering medications like rosuvastatin.

Aging Population: The global population is aging rapidly, with a significant increase expected in the 65+ age group, a demographic more susceptible to CVDs and requiring cholesterol management solutions.

Focus on Preventive Care: Growing awareness about preventive healthcare is leading to increased use of statins like rosuvastatin, even in individuals with borderline high cholesterol levels.

Drivers and Restraints

Several factors are propelling the rosuvastatin market forward:

Patent Expiry and Generic Availability: The expiration of patents on rosuvastatin has led to the emergence of generic alternatives, making the drug more affordable and accessible to a wider patient pool.

Growing Focus on Personalized Medicine: Personalized medicine approaches are tailoring treatment plans based on individual patient needs. Rosuvastatin can be combined with other medications for a more comprehensive cholesterol management strategy.

Government Initiatives: Government healthcare initiatives supporting CVD prevention and medication access further drive market growth.

Click here to Get customization @ https://www.reportsanddata.com/request-customization-form/1650

However, certain challenges may impede market expansion:

Safety Concerns: While generally well-tolerated, rosuvastatin can cause side effects in some patients.

Stringent Regulatory Requirements: Stringent regulations for drug development and approval can hinder the introduction of innovative rosuvastatin formulations.

Competition from Alternative Cholesterol-Lowering Drugs: New classes of cholesterol-lowering drugs like PCSK9 inhibitors may pose some competition to rosuvastatin in the future.

Growth Opportunities

Despite these restraints, the rosuvastatin market presents significant growth opportunities:

Development of Novel Formulations: Pharmaceutical companies are exploring novel rosuvastatin formulations with improved delivery methods and targeted action mechanisms.

Emerging Markets: Developing economies with rising disposable incomes and increasing healthcare awareness present untapped market potential.

Online Pharmacies: The growing popularity of online pharmacies provides a convenient platform for patients to access rosuvastatin and other CVD medications.

Key Market Insights

The main competitors to Rosuvastatin are Atorvastatin and Simvastatin, along with the strict regulations and intellectual property rights are the restraints on the businesses. However, the availability of generic products, competition among generic companies, and increasing investment in R&D are expected to open new opportunities in the coming years globally. North America owns the majority of the share owing to the prevalence of obesity, preference of non-surgical treatment, raising awareness, and advanced healthcare infrastructure. Europe is the second, followed by Asia-Pacific. The Rosuvastatin market in Asia-Pacific is expected to grow the highest during the forecast period because of a large patient pool and the developing healthcare infrastructure.

The document provides an investigation of the rosuvastatin marketplace to predict its prospects. The past data is considered from the years 2016 and 2017 while taking 2018 as the base year to estimate the trends in the years 2019 to 2026. The industry has been categorized into different segments based on type as Purity 99.0%, Purity 98.0%; based on form by Capsule, Tablet; and based on distribution channel as Hospital pharmacies, Retail pharmacies & drug stores, online stores, to assess their size, share, demand, trends, gross profit, total earnings, revenue and speculate their further aspects. This report also evaluates the competition in the business to derive the individual placements of the key players in the global sector. The information provided here outlines those sectors that are expected to undergo substantial developments in the predicted years to aid the readers in deciphering the most profitable ones for their business. By doing so, it also highlights the sectors that exhibit significant potential for investment.

Find More Competitor in TOC with Profile Overview Share Growth Analysis @ https://www.reportsanddata.com/report-detail/rosuvastatin-market

SWOT Analysis

Strengths:

Proven efficacy and safety profile of rosuvastatin

Generic availability and affordability

Established market presence

Weaknesses:

Potential side effects

Patent expiry and generic competition

Opportunities:

Development of novel formulations

Growing demand in emerging markets

Rise of online pharmacies

Threats:

Stringent regulations

Competition from alternative cholesterol-lowering drugs

Key players in the global rosuvastatin market:

AstraZeneca

Teva Pharmaceutical Industries

MSN Laboratories

Cadila Pharmaceuticals

LGM Pharma

Changzhou Pharmaceutical Factory

Jingxin Pharm

HEC Pharm

Lunan Pharmaceutical

Lianyungang Runzhong Pharmaceutical

Shandong Bechem Chemicals

CTX Life Sciences

Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision.

This release was published on openPR.